The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
Presented on 08 December 2020
Tuesday 8th December 2020 12.30pm EST; 5.30pm UK
McIntyre RS, Rodrigues NB, Lipsitz O, Nasri F, Gill H, Lui LM, Subramaniapillai M, Kratiuk K, Teopiz K, Ho R, Lee Y, Mansur RB, Rosenblat JD. J Psychopharmacol. 2020 Oct 11 Epub ahead of print.
Presenter: Roger McIntyre, Professor of Psychiatry and Pharmacology, University of Toronto